ReCor Medical Receives CE Mark for its Generation 2, Ultrasound-based PARADISE™ Renal Denervation System

Published: Jan 24, 2013

MENLO PARK, Calif.--(BUSINESS WIRE)--ReCor Medical announced today that it has received CE mark for its next-generation PARADISE system, a minimally invasive 6Fr over-the-wire (OTW) ultrasound device for treating resistant high blood pressure. Additionally, the treatment parameters of Gen 2 have been further enhanced to reduce energy delivery to 30 seconds by maximizing cooling of the endothelium and efficiently treating the nerves circumferentially. A live case is planned Friday, January 25, 2013, at the ‘LINC’ (Leipzig Interventional Course) meeting in Leipzig, Germany.

Back to news